Hunan Fangsheng Pharmaceutical Co., Ltd.
Status: Publicly traded
Direct answer
Hunan Fangsheng Pharmaceutical Co., Ltd. is publicly traded on SHH under the ticker 603998.SS.
Operating within China, Hunan Fangsheng Pharmaceutical Co., Ltd. is engaged in the complete spectrum of pharmaceutical activities, from research and development to manufacturing and sales. Its diverse product line encompasses tablets, capsules, and granules, addressing a wide array of therapeutic areas such as cardiovascular, cerebrovascular, orthopedic, pediatric, gynecological, traumatology, and anti-infective...
Can you invest in Hunan Fangsheng Pharmaceutical Co., Ltd.?
Yes. Hunan Fangsheng Pharmaceutical Co., Ltd. trades publicly on SHH as 603998.SS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Hunan Fangsheng Pharmaceutical Co., Ltd.
Detailed equity research is provided by MarketSnap.